Showing results (141-150 of 302) with videos related to
Sort By:
Pageof 31
Clinical Colorectal Cancer|March 18, 2004
Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancerAndrew X Zhu, Thomas A Puchalski, Vincent P Stanton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2013
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimensKimmie Ng, Josep Tabernero, Jimmy Hwang, et al.Pancreas|November 16, 2016
Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant TreatmentRyan D Nipp, Andrea Zanconato, Hui Zheng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid tumorsAndrew X Zhu, Neal Ready, Jeffrey W Clark, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumorsLinda L Garland, Manuel Hidalgo, David S Mendelson, et al.Archives of Surgery (Chicago, Ill. : 1960)|November 19, 2008
A randomized controlled trial to improve lymph node assessment in stage II colon cancerFrances C Wright, Anna R Gagliardi, Calvin H L Law, et al.Digestive Diseases and Sciences|January 18, 2006
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger, Matthew H Kulke, Jeffrey W Clark, et al.The Oncologist|December 20, 2002
A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumorsDavid P Ryan, Thomas Puchalski, Jeffrey G Supko, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancerJeffrey A Meyerhardt, Andrew X Zhu, Peter C Enzinger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumorsMatthew H Kulke, Jason L Hornick, Christine Frauenhoffer, et al.Pageof 31